During the past decade, Prairie Lakes Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prairie Lakes Cancer Center" #1 collaborator was "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Prairie Lakes Cancer Center" are "Non-small Cell Lung Cancer" (1 trials), "Part 1：r/r B-cell Malignancies" (1 trials), "Part 2：B-cell Malignancies" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Prairie Lakes Cancer Center" in a lesser frequency.

Most popular intervention types in "Prairie Lakes Cancer Center" are "Drug" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Orelabrutinib (ICP-022)" (1 trials), "Pembrolizumab" (1 trials), "Pemetrexed" (1 trials), "Tomivosertib" (1 trials) and "stereotactic body radiation therapy (SBRT) - 47.5 Gy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prairie Lakes Cancer Center" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Prairie Lakes Cancer Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Prairie Lakes Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Prairie Lakes Cancer Center, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".